Preexposure prophylaxis for HIV--where do we go from here?
Myron S
MS
Cohen
Lindsey R
LR
Baden
D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000068679:Emtricitabine; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D015497:HIV-1; D006801:Humans; D008297:Male; D063065:Organophosphonates / Q000627:therapeutic use*; D011247:Pregnancy; D000068698:Tenofovir
D044966:Anti-Retroviral Agents; D063065:Organophosphonates; D003841:Deoxycytidine; D000068698:Tenofovir; D000068679:Emtricitabine; D000225:Adenine